MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Posted on Nov 10, 2021, 1:15 am
#1

Any doctor better than Betz with internal nail available right now?

Like (0)
Posted on Nov 10, 2021, 11:32 am
#2

Quote from: BreaktoGrow on November 10, 2021, 01:15:45 AMAny doctor better than Betz with internal nail available right now?


Most doctors in the world must have Precise nail available by now and Guichet and Giotikas also have the guichet nail.

Like (0)
Posted on Nov 10, 2021, 2:17 pm
#3

Assayag is also probably one of the best and ethical.

Like (0)
Posted on Nov 10, 2021, 7:33 pm
#4

Good teams in the world

1) Paley Institute
2) International Center for LL Baltimore
3) Hospital for Special Surgery New York

They all offer Precice. I was thinking of using Guichet nail or Betzbone too but now I think it's safer to just do Precice in the US. These centers have more than one expert doctor each.

Like (0)
Posted on Nov 10, 2021, 7:58 pm
#5

Thanks for the response. I should have clarified that I'm looking for weight bearing. Being in a wheel chair for several months would be incredibly difficult on mental health, I imagine.

Like (0)
Posted on Nov 11, 2021, 4:17 pm
#6

Idk your times or desires but if u can wait one or two more years just wait for a more reliable nail .
Betz or albizza from what I've seen are really painfull and u can't reserve the lengthening (most likely you would not need that feature but you never know) .
I would not get precice no matter what so I understand your point of view but I would wait for stryde return or the new nail of nuvasive .
Also Nitinail from Synoste will probably be available in 2023 since test end in late 2022 so given the stryde problems ,I would bet more on that Nail rather then betz or albizza even if Stryde doesen't come back .
That's what I would do at least

Like (0)
Posted on Nov 11, 2021, 4:31 pm
#7

Be careful about "new" Stryde at least until you know if it was tested in animals and first year of human use:

"Overall, 77% of STRYDE nails (20/26) had bone abnormalities at the interface compared with only 2% of FITBONE (4/242) and 1% of PRECICE nails (1/98; p < 0.001). Focal osteolysis in conjunction with periosteal reaction at the telescoping interface was only observed in STRYDE nails."

Link:
https://online.boneandjoint.org.uk/doi/full/10.1302/0301-620X.103B.BJJ-2021-0549.R1?utm_source=TrendMD&utm_medium=cpc&utm_campaign=The_Bone_%2526_Joint_Journal_TrendMD_0

Like (0)
Posted on Nov 11, 2021, 4:42 pm
#8

Quote from: zaozari on November 11, 2021, 04:31:56 PMBe careful about "new" Stryde at least until you know if it was tested in animals and first year of human use:

"Overall, 77% of STRYDE nails (20/26) had bone abnormalities at the interface compared with only 2% of FITBONE (4/242) and 1% of PRECICE nails (1/98; p < 0.001). Focal osteolysis in conjunction with periosteal reaction at the telescoping interface was only observed in STRYDE nails."

Link:
https://online.boneandjoint.org.uk/doi/full/10.1302/0301-620X.103B.BJJ-2021-0549.R1?utm_source=TrendMD&utm_medium=cpc&utm_campaign=The_Bone_%2526_Joint_Journal_TrendMD_0


Honestly ? I think they will make another nail because stryde released in 2018 and by 2023 there will be already 5 years between ...and in 5 years the company could have kept working on better one .
I don't think a competitive company as Nuvasive wants to lose their monopolies by not updating and making a full weight bearing nail their ace in 2023 .
Stryde only issues was the corrosion due to material ,too much load and so on ( only but very concerning ofc) , but I feel like a huge company like Nuvasive will not want to repeat the same error again or other companies like Synoste will get the lead .
So looking at it from a business perspective I believe in a new nail from the scratch (remember that stryde has been realead in 2018 but probably set at least 1 or 2 year prior so the company probably started working on another nail back then ) .
Those are all speculations tho but with those companies / doctors you have to look at it more on a business perspective according to me .

Like (0)
Posted on Nov 11, 2021, 5:03 pm
#9

I can recommen Dr.Koehne in Germany, hes been using precise since it came out. Actually the majority of his patients are leg length discreptancy patients, so naturally he has a lot of experience.

Like (0)
Posted on Nov 11, 2021, 6:29 pm
#10

Quote from: Masteryourlife on November 11, 2021, 04:42:45 PMHonestly ? I think they will make another nail because stryde released in 2018 and by 2023 there will be already 5 years between ...and in 5 years the company could have kept working on better one .
I don't think a competitive company as Nuvasive wants to lose their monopolies by not updating and making a full weight bearing nail their ace in 2023 .
Stryde only issues was the corrosion due to material ,too much load and so on ( only but very concerning ofc) , but I feel like a huge company like Nuvasive will not want to repeat the same error again or other companies like Synoste will get the lead .
So looking at it from a business perspective I believe in a new nail from the scratch (remember that stryde has been realead in 2018 but probably set at least 1 or 2 year prior so the company probably started working on another nail back then ) .
Those are all speculations tho but with those companies / doctors you have to look at it more on a business perspective according to me .


Ok, you "want" to like Stryde. (I understand, I also wanted it two). The truth is that such a big, responsible, company made bull***. Allmost for sure for example they didn't tested it on mammals. A new "Stryde" should only make us more cautious, not the opposite. In medicine, testing and experience makes the difference, novelty itself is not good, only after good tests, good trials and clinical use. It's not like fashion or mobile phones.
Take this too (there are more but as I said you seem to "want" Stryde).

https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.103B6.BJJ-2020-2165.R1?utm_source=TrendMD&utm_medium=cpc&utm_campaign=The_Bone_%2526_Joint_Journal_TrendMD_0

Like (0)

You must be logged in to post a reply.

Related Topics